In the evolving landscape of radiology, KA Imaging presents pioneering research on portable dual-energy tomosynthesis at ECR 2024. Through innovative studies and technical exhibitions, KA Imaging showcases the transformative potential of SpectralDR technology in enhancing diagnostic accuracy and patient care. By integrating material discrimination capabilities with the precision of tomosynthesis, portable dual-energy imaging promises to revolutionize radiological practices, offering a viable alternative to conventional CT scans. This paradigm shift underscores KA Imaging’s commitment to driving innovation and fostering excellence in diagnostic radiology.
Radiology is experiencing a seismic shift with the advent of portable dual-energy tomosynthesis, a revolutionary approach poised to redefine diagnostic imaging standards. KA Imaging’s participation at ECR 2024 heralds a new era of innovation, as researchers explore the fusion of SpectralDR technology with tomosynthesis to enhance diagnostic accuracy and improve patient outcomes. By leveraging advancements in material discrimination and image acquisition, portable dual-energy tomosynthesis holds immense promise in streamlining diagnostic workflows and expanding access to high-quality imaging, particularly in resource-limited settings. This introduction sets the stage for a comprehensive examination of KA Imaging’s groundbreaking contributions to the field of radiology.
Tilley’s presentation, centered around the groundbreaking study titled “Dual-Energy Tomosynthesis of the Chest using a Triple Layer X-ray Detector,” promises to unveil the transformative potential of this innovative approach. Quoting directly from the proof-of-concept study, the integration of material separation capabilities inherent in dual-energy imaging with the depth localization precision of tomosynthesis holds the promise of furnishing comprehensive patient information, potentially obviating the need for costly computed tomography (CT) scans for a multitude of patients.
The adoption of SpectralDR technology for dual energy represents a quantum leap forward, superseding archaic multiple-exposure methodologies and paving the way for portable, spectral tomosynthesis. Amol Karnick, the President and CEO of KA Imaging underscores the significance of optimizing hospital resources to alleviate the burdens on both staff and patients. Karnick emphasizes the potential of bedside imaging solutions to enhance patient care while minimizing risks associated with patient transportation, particularly in critical care settings such as the Intensive Care Unit (ICU).
CTO Karim S. Karim reinforces the pivotal role played by spectral tomosynthesis in revolutionizing diagnostic imaging. Karim accentuates the unparalleled capabilities of the Reveal detector equipped with SpectralDR technology, enabling precise material discrimination and identification—a feature conspicuously absent in conventional tomosynthesis solutions. Spectral tomosynthesis not only mirrors the advantages of traditional tomosynthesis such as higher throughput and flexible patient positioning but also augments it with the invaluable capability of material discrimination, potentially rivaling the diagnostic efficacy of fixed CT scans.
A pivotal aspect of KA Imaging’s presentation repertoire at ECR 2024 is the study titled “Dual-energy acquisition of portable chest X-rays: added diagnostic value in a non-radiological reviewing environment,” spearheaded by radiologist Dr. Patrik Rogalla. This study delves into the added diagnostic value conferred by dual-energy acquisition in the realm of portable chest X-rays, particularly in non-radiological reviewing environments. Through a comprehensive survey encompassing international reviewers with diverse experience levels, the study illuminates the enhanced diagnostic efficacy and confidence engendered by dual-energy images captured by the Reveal 35C detector.
Findings from the study are nothing short of revelatory, indicating a statistically insignificant change in median reading time for a single Digital Radiography (DR) versus three images captured by the Reveal 35C. Moreover, lines and tubes were discernibly better visualized in dual-energy images, underscoring their superior diagnostic clarity and precision. Perhaps most significantly, dual-energy images elicited markedly increased confidence among the majority of reviewers, underscoring their potential to redefine diagnostic standards in non-radiological reviewing environments.
In addition to its scholarly contributions, KA Imaging is set to captivate audiences at the technical exhibition of ECR 2024, showcasing its flagship Reveal 35C detector (CE Marked) alongside innovative mobile solutions. Attendees will have the opportunity to peruse real clinical cases, providing invaluable insights into the practical applications and transformative potential of KA Imaging’s cutting-edge technologies. Positioned at Expo X2 (Lower Level), booth #226, KA Imaging invites participants to embark on a journey of exploration and discovery, charting the course toward a future where portable dual-energy tomosynthesis redefines the landscape of diagnostic radiology.
As the curtains draw to a close on ECR 2024, KA Imaging emerges as a trailblazer in the realm of portable dual-energy tomosynthesis, showcasing the transformative potential of SpectralDR technology in revolutionizing diagnostic radiology. Through innovative studies, technical exhibitions, and scholarly discourse, KA Imaging has demonstrated the efficacy of portable dual-energy imaging in enhancing diagnostic accuracy, improving workflow efficiency, and advancing patient care paradigms. As the radiological community embraces these advancements, KA Imaging remains steadfast in its commitment to driving innovation, fostering collaboration, and shaping the future of diagnostic radiology for the betterment of patients worldwide.
